Piper Jaffray Remains Bullish on Endologix (ELGX) Following Travels with CEO
Tweet Send to a Friend
Piper Jaffray reiterated an Overweight rating and $20.00 price target on Endologix (NASDAQ: ELGX) following recent travels with CEO John ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE